194669-38-0

Basic information

• Product Name: tert-butyl 4-(2-cyanophenyl)-5,6-dihydropyridine-1(2H)-carboxylate
• Synonyms: tert-butyl 4-(2-cyanophenyl)-5,6-dihydropyridine-1(2H)-carboxylate;1(2H)-Pyridinecarboxylic acid, 4-(2-cyanophenyl)-3,6-dihydro-, 1,1-dimethylethyl ester
• CAS NO: 194669-38-0
• Molecular Formula: C₁₇H₂₀N₂O₂
• Molecular Weight: 284.3529
• Mol File: 194669-38-0.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4-(2-cyanophenyl)-5,6-dihydropyridine-1(2H)-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(2-cyanophenyl)-5,6-dihydropyridine-1(2H)-carboxylate(194669-38-0)
• EPA Substance Registry System: tert-butyl 4-(2-cyanophenyl)-5,6-dihydropyridine-1(2H)-carboxylate(194669-38-0)

Safety Data

• Hazardous Substances Data: 194669-38-0(Hazardous Substances Data)

Usage

General Description

Tert-butyl 4-(2-cyanophenyl)-5,6-dihydropyridine-1(2H)-carboxylate is a chemical compound with the molecular formula C18H20N2O2. It is a dihydropyridine derivative, which is a class of organic compounds with wide-ranging pharmaceutical and biological activities. This specific compound is a tert-butyl ester of 4-(2-cyanophenyl)-5,6-dihydropyridine-1(2H)-carboxylic acid, and it has been studied for its potential use in the development of new drugs and pharmaceuticals. The compound's structure and properties make it a promising candidate for further research and potential applications in the field of medicinal chemistry.

Upstream product

• 138647-49-1 4-Trifluoromethanesulfonyloxy-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 4387-36-4 2-iodobenzonitrile 
• 375853-82-0 tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 2042-37-7 o-cyanobromobenzene 
• 138642-62-3 2-Cyanophenylboronic acid 
• 148651-34-7 iodo(2-cyanophenyl)zinc 

Downstream Products

• 256951-72-1 tert-butyl 4-(2-cyanophenyl)piperidine-1-carboxylate 
• 304462-63-3 2-(piperidin-4-yl)benzonitrile 
• 1394387-80-4 2-(1-(2-((3-isopropylisoxazol-5-yl)methylamino)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)benzonitrile 
• 1574730-66-7 2-(1-(2-aminoethyl)-1,2,3,6-tetrahydropyridin-4-yl)benzonitrile 
• 1574730-92-9 2-(1-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)benzonitrile 
• 256951-73-2 2-(piperidin-4-yl)benzonitrile hydrochloride 
• 256951-74-3 2-[1-(3-tert-butoxycarbonylaminopropyl)-piperidin-4-yl] benzonitrile 

Relevant articles and documents

PHENYL mTORC INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

GLYCOSIDASE INHIBITORS

Compounds of formula (I) wherein X1, X2, W, R1 to R5, L and m have the meaning according to the claims, are glucosidase inhibitors, and can be employed, inter alia, for the treatment of Alzheimer's disease.

Alpha 1A adrenergic receptor antagonists

This invention relates to certain novel compounds and derivatives thereof, their synthesis, and their use as alpha 1a adrenergic receptor antagonists. One application of these compounds is in the treatment of benign prostatic hyperplasia. These compounds are selective in their ability to relax smooth muscle tissue enriched in the alpha 1a receptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia are achieved.